• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Cross Country Healthcare Inc. (Amendment)

    10/28/22 4:22:40 PM ET
    $CCRN
    Professional Services
    Consumer Discretionary
    Get the next $CCRN alert in real time by email
    SC 13D/A 1 sc13da107902010_10282022.htm AMENDMENT NO. 1 TO THE SCHEDULE 13D

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 13D

    (Rule 13d-101)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    § 240.13d-2(a)

    (Amendment No. 1)1

    Cross Country Healthcare, Inc.

    (Name of Issuer)

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

    227483104

    (CUSIP Number)

    JEFFREY JACOBOWITZ

    SIMCOE CAPITAL MANAGEMENT, LLC

    540 Madison Avenue, 27th Floor

    New York, New York 10022

    (212) 448-7400

     

    STEVE WOLOSKY, ESQ.

    OLSHAN FROME WOLOSKY LLP

    1325 Avenue of the Americas

    New York, New York 10019

    (212) 451-2300

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

     

    October 26, 2022

    (Date of Event Which Requires Filing of This Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.

    Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    1              The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 227483104

      1   NAME OF REPORTING PERSON  
             
            SIMCOE CAPITAL MANAGEMENT, LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            AF  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         1,613,581  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              1,613,581  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            1,613,581  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            4.2%  
      14   TYPE OF REPORTING PERSON  
             
            OO  

      

    2

    CUSIP No. 227483104

      1   NAME OF REPORTING PERSON  
             
            SIMCOE PARTNERS, L.P.  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         1,472,375  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              1,472,375  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            1,472,375  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            3.9%  
      14   TYPE OF REPORTING PERSON  
             
            PN  

      

    3

    CUSIP No. 227483104

     

      1   NAME OF REPORTING PERSON  
             
            SIMCOE SELECT, L.P.  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         82,403  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              82,403  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            82,403  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            Less than 1%  
      14   TYPE OF REPORTING PERSON  
             
            PN  

      

    4

    CUSIP No. 227483104

     

      1   NAME OF REPORTING PERSON  
             
            SIMCOE MANAGEMENT COMPANY, LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            AF  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         1,554,778  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              1,554,778  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            1,554,778  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            4.1%  
      14   TYPE OF REPORTING PERSON  
             
            OO  

      

    5

    CUSIP No. 227483104

     

      1   NAME OF REPORTING PERSON  
             
            SDR PARTNERS, LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         58,803  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              58,803  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            58,803  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            Less than 1%  
      14   TYPE OF REPORTING PERSON  
             
            OO  

      

    6

    CUSIP No. 227483104

     

      1   NAME OF REPORTING PERSON  
             
            JEFFREY JACOBOWITZ  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            AF  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            USA  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         1,613,581  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              1,613,581  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            1,613,581  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            4.2%  
      14   TYPE OF REPORTING PERSON  
             
            IN  

      

    7

    CUSIP No. 227483104

    The following constitutes Amendment No. 1 to the Schedule 13D filed by the undersigned (“Amendment No. 1”). This Amendment No. 1 amends the Schedule 13D as specifically set forth herein.

    Item 3.Source and Amount of Funds or Other Consideration.

    Item 3 is hereby amended and restated to read as follows:

    The Shares purchased by each of Simcoe Partners, Simcoe Select and SDR Partners were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases. The aggregate purchase price of the 1,472,375 Shares directly owned by Simcoe Partners is approximately $22,232,109, including brokerage commissions. The aggregate purchase price of the 82,403 Shares directly owned by Simcoe Select is approximately $1,553,088 including brokerage commissions. The aggregate purchase price of the 58,803 Shares directly owned by SDR Partners is approximately $1,224,545, including brokerage commissions.

    Item 5.Interest in Securities of the Issuer.

    Item 5 is hereby amended and restated to read as follows:

    The aggregate percentage of Shares reported owned by each person named herein is based upon 38,231,338 Shares outstanding, as of July 21, 2022, which is the total number of Shares outstanding as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 4, 2022.

    A.Simcoe Partners
    (a)As of the date hereof, Simcoe Partners directly owned 1,472,375 Shares.

    Percentage: 3.9%

    (b)1. Sole power to vote or direct vote: 1,472,375
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 1,472,375
    4. Shared power to dispose or direct the disposition: 0

     

    (c)The transactions in the Shares by Simcoe Partners since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.
    B.Simcoe Select
    (a)As of the date hereof, Simcoe Select directly owned 82,403 Shares.

    Percentage: Less than 1%

    (b)1. Sole power to vote or direct vote: 82,403
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 82,403
    4. Shared power to dispose or direct the disposition: 0

     

    (c)The transactions in the Shares by Simcoe Select since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.
    8

    CUSIP No. 227483104

    C.Simcoe Management
    (a)Simcoe Management, as the general partner of Simcoe Partners and Simcoe Select, may be deemed the beneficial owner of the (i) 1,472,375 Shares owned by Simcoe Partners and (ii) 82,403 Shares owned by Simcoe Select.

    Percentage: 4.1%

    (b)1. Sole power to vote or direct vote: 1,554,778
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 1,554,778

    4. Shared power to dispose or direct the disposition: 0

     

    (c)Simcoe Management has not entered into any transactions in the Shares during the past sixty days. The transactions in the Shares on behalf of Simcoe Partners and Simcoe Select since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.
    D.SDR Partners
    (a)As of the date hereof, SDR Partners directly owned 58,803 Shares.

    Percentage: Less than 1%

    (b)1. Sole power to vote or direct vote: 58,803
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 58,803
    4. Shared power to dispose or direct the disposition: 0

     

    (c)The transactions in the Shares by SDR Partners since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.
    E.Simcoe Capital
    (a)Simcoe Capital, as the investment manager to each of Simcoe Partners, Simcoe Select and SDR Partners, may be deemed the beneficial owner of the (i) 1,472,375 Shares owned by Simcoe Partners, (ii) 82,403 Shares owned by Simcoe Select and (iii) 58,803 Shares owned by SDR Partners.

    Percentage: 4.2%

    (b)1. Sole power to vote or direct vote: 1,613,581
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 1,613,581

    4. Shared power to dispose or direct the disposition: 0

     

    (c)Simcoe Capital has not entered into any transactions in the Shares since the filing of the Schedule 13D. The transactions in the Shares on behalf of each of Simcoe Partners, Simcoe Select and SDR Partners since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.
    9

    CUSIP No. 227483104

    F.Mr. Jacobowitz
    (a)Mr. Jacobowitz, as Managing Member of each of Simcoe Management and Simcoe Capital, may be deemed the beneficial owner of the (i) 1,472,375 Shares owned by Simcoe Partners (ii) 82,403 Shares owned by Simcoe Select and (iii) 58,803 Shares owned by SDR Partners.

    Percentage: 4.2%

    (b)1. Sole power to vote or direct vote: 1,613,581
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 1,613,581

    4. Shared power to dispose or direct the disposition: 0

     

    (c)Mr. Jacobowitz has not entered into any transactions in the Shares since the filing of the Schedule 13D. The transactions in the Shares on behalf of each of Simcoe Partners, Simcoe Select and SDR Partners since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.

    Each Reporting Person, as a member of a “group” with the other Reporting Persons for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, may be deemed the beneficial owner of the Shares directly owned by the other Reporting Persons. Each Reporting Person disclaims beneficial ownership of such Shares except to the extent of his or its pecuniary interest therein.

    (d)No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.
    (e)As of October 26, 2022, the Reporting Persons ceased to beneficially own more than 5% of the outstanding Shares of the Issuer.

     

    10

    CUSIP No. 227483104

    SIGNATURES

    After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated: October 28, 2022

      Simcoe Partners, L.P.
       
      By:

    Simcoe Management Company, LLC

    General Partner

         
      By: /s/ Jeffrey Jacobowitz
        Name: Jeffrey Jacobowitz
        Title: Managing Member

     

      Simcoe Select, L.P.
       
      By:

    Simcoe Management Company, LLC

    General Partner

         
      By: /s/ Jeffrey Jacobowitz
        Name: Jeffrey Jacobowitz
        Title: Managing Member

     

      Simcoe Management Company, LLC
       
      By: /s/ Jeffrey Jacobowitz
        Name: Jeffrey Jacobowitz
        Title: Managing Member

     

      SDR Partners, LLC
       
      By:

    Simcoe Capital Management, LLC

    Investment Manager

         
      By: /s/ Jeffrey Jacobowitz
        Name: Jeffrey Jacobowitz
        Title: Managing Member

     

      Simcoe Capital Management, LLC
       
      By: /s/ Jeffrey Jacobowitz
        Name: Jeffrey Jacobowitz
        Title: Managing Member

     

      /s/ Jeffrey Jacobowitz
      Jeffrey Jacobowitz

     

    11

    CUSIP No. 227483104

    SCHEDULE A

    Transactions in the Shares Since the Filing of the Schedule 13D

    Shares of Common Stock

    Purchased/(Sold)

    Price Per

    Share($)

    Date of

    Purchase/Sale

     

    SIMCOE PARTNERS, L.P.

     

    (113,458) 37.3359 10/24/2022
    (170,966) 36.3908 10/25/2022
    (214,791) 36.7828 10/26/2022
    (98,610) 36.6694 10/27/2022

     

    SIMCOE SELECT, L.P.

     

    (7,669) 37.3359 10/24/2022
    (11,555) 36.3908 10/25/2022
    (14,518) 36.7828 10/26/2022
    (11,029) 36.6694 10/27/2022

     

    SDR PARTNERS, LLC

     

    (3,873) 37.3359 10/24/2022
    (5,837) 36.3908 10/25/2022
    (7,333) 36.7828 10/26/2022
    (4,878) 36.6694 10/27/2022

     

    Get the next $CCRN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CCRN

    DatePrice TargetRatingAnalyst
    12/10/2024Outperform → Mkt Perform
    Barrington Research
    12/6/2023Mkt Perform
    JMP Securities
    11/3/2023$32.00 → $21.00Buy → Hold
    Jefferies
    6/26/2023Outperform
    William Blair
    3/10/2023$30.00Buy
    Loop Capital
    10/5/2022$36.00Buy → Hold
    Truist
    2/24/2022$33.00 → $42.00Buy
    Benchmark
    1/27/2022$18.00 → $27.00Hold → Buy
    Jefferies
    More analyst ratings

    $CCRN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cross Country Healthcare Announces First Quarter 2025 Financial Results

      Cross Country Healthcare, Inc. (the Company) (NASDAQ:CCRN) today announced financial results for its first quarter ended March 31, 2025. SELECTED FINANCIAL INFORMATION:       Variance Variance       Q1 2025 vs Q1 2025 vs Dollars are in thousands, except per share amounts Q1 2025 Q1 2024 Q4 2024 Revenue $ 293,408       (23 ) %   (5 ) % Gross profit margin*   20.0   %   (40 ) bps   —   bps Net loss attributable to common stockholders $ (490 )     (118 ) %   87   % Diluted EPS $ (0.02 )   $ (0.10 )

      5/7/25 4:15:00 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Cross Country Healthcare Stockholders Approve Aya Healthcare Transaction

      Cross Country Healthcare, Inc. ("Cross Country" or the "Company") (NASDAQ:CCRN) today announced that the Company has obtained all requisite stockholder approvals in connection with its proposed acquisition by Aya Healthcare. As previously disclosed, Cross Country and Aya Healthcare expect to complete the transaction in the second half of 2025, subject to the satisfaction or waiver of customary closing conditions specified in the Merger Agreement. Upon completion of the transaction, Cross Country will become a private company and its common stock will no longer trade on the NASDAQ. Cross Country will file the final, certified voting results on a Form 8-K with the U.S. Securities and Exch

      2/28/25 4:48:00 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Aya Healthcare to Acquire Cross Country Healthcare for Approximately $615 Million in Cash

      Cross Country stockholders to receive $18.61 per share Expands Aya's client service and delivery capabilities with Cross Country's nearly 40-year history of clinical excellence and quality patient care Provides clinicians with greater flexibility and convenience by tapping into the combined pool of nationwide opportunities, with competitive compensation and a world-class experience Creates immediate stockholder value for Cross Country, through a nearly 67 percent premium Aya Healthcare and Cross Country Healthcare today announced that they have entered into a definitive agreement whereby Aya will acquire Cross Country for $18.61 per share in cash in a transaction valued at appr

      12/4/24 7:45:00 AM ET
      $CCRN
      Professional Services
      Consumer Discretionary

    $CCRN
    Leadership Updates

    Live Leadership Updates

    See more
    • Aya Healthcare to Acquire Cross Country Healthcare for Approximately $615 Million in Cash

      Cross Country stockholders to receive $18.61 per share Expands Aya's client service and delivery capabilities with Cross Country's nearly 40-year history of clinical excellence and quality patient care Provides clinicians with greater flexibility and convenience by tapping into the combined pool of nationwide opportunities, with competitive compensation and a world-class experience Creates immediate stockholder value for Cross Country, through a nearly 67 percent premium Aya Healthcare and Cross Country Healthcare today announced that they have entered into a definitive agreement whereby Aya will acquire Cross Country for $18.61 per share in cash in a transaction valued at appr

      12/4/24 7:45:00 AM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • The Ensign Group Set to Join S&P MidCap 400; Curbline Properties & TransMedics Group to Join S&P SmallCap 600

      NEW YORK, Sept. 26, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 and S&P MidCap 400: S&P SmallCap 600 constituent The Ensign Group Inc. (NASD: ENSG) will replace Southwestern Energy Co. (NYSE:SWN) in the S&P MidCap 400 and TransMedics Group, Inc. (NASD: TMDX) will replace The Ensign Group in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, October 1.  S&P MidCap 400 constituent Chesapeake Energy Corp. (NASD: CHK) is acquiring Southwestern Energy in a deal expected to be completed October 1.Curbline Properties Corp. (NYSE:CURB) will be added to the S&P SmallCap 600 effective prior to the open of trading on Tuesda

      9/26/24 6:04:00 PM ET
      $CCRN
      $CHK
      $ENSG
      $SITC
      Professional Services
      Consumer Discretionary
      Oil & Gas Production
      Energy
    • Cross Country Healthcare Appoints Phillip Noe as Chief Information Officer

      Cross Country Healthcare, Inc., (NASDAQ:CCRN), a leading provider of advisory and workforce solutions including contingent staffing, permanent placement, and other consultative services for healthcare clients, has appointed Phillip Noe to the role of Chief Information Officer (CIO). Noe replaces Bill Halnon who is retiring, and will report directly to Kevin C. Clark, Co-founder and CEO. He commences May 10, 2021. "Phil's appointment reflects the ongoing evolution of our digital transformation at Cross Country," said Kevin C. Clark, Co-founder and Chief Executive Officer of Cross Country Healthcare. "His extensive experience in information technology spans every aspect of the software engin

      5/10/21 4:15:00 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary

    $CCRN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Cross Country Healthcare Inc.

      SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)

      11/13/24 9:39:57 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Cross Country Healthcare Inc.

      SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)

      11/13/24 4:36:10 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Cross Country Healthcare Inc. (Amendment)

      SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)

      2/13/24 5:02:31 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary

    $CCRN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Group President, Delivery Krug Marc S. covered exercise/tax liability with 5,649 shares, decreasing direct ownership by 14% to 34,853 units (SEC Form 4)

      4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

      4/2/25 4:44:41 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Chief Financial Officer Burns William J. covered exercise/tax liability with 13,465 shares, decreasing direct ownership by 5% to 242,508 units (SEC Form 4)

      4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

      4/2/25 4:43:42 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • General Counsel and Secretary Ball Susan E covered exercise/tax liability with 9,386 shares, decreasing direct ownership by 5% to 176,032 units (SEC Form 4)

      4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

      4/2/25 4:43:08 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary

    $CCRN
    Financials

    Live finance-specific insights

    See more
    • Cross Country Healthcare Announces First Quarter 2025 Financial Results

      Cross Country Healthcare, Inc. (the Company) (NASDAQ:CCRN) today announced financial results for its first quarter ended March 31, 2025. SELECTED FINANCIAL INFORMATION:       Variance Variance       Q1 2025 vs Q1 2025 vs Dollars are in thousands, except per share amounts Q1 2025 Q1 2024 Q4 2024 Revenue $ 293,408       (23 ) %   (5 ) % Gross profit margin*   20.0   %   (40 ) bps   —   bps Net loss attributable to common stockholders $ (490 )     (118 ) %   87   % Diluted EPS $ (0.02 )   $ (0.10 )

      5/7/25 4:15:00 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Cross Country Healthcare to Hold Third Quarter 2024 Earnings Conference Call on Wednesday, November 6, 2024

      Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its third quarter 2024 financial results on Wednesday, November 6, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, November 6, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from November 6th through November 20th on the Company's website and a replay of the

      10/18/24 4:15:00 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Cross Country Healthcare Announces Second Quarter 2024 Financial Results

      Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) today announced financial results for its second quarter ended June 30, 2024. SELECTED FINANCIAL INFORMATION:       Variance Variance       Q2 2024 vs Q2 2024 vs Dollars are in thousands, except per share amounts Q2 2024 Q2 2023 Q1 2024 Revenue $ 339,771       (37 ) %   (10 ) % Gross profit margin*   20.8   %   (200 ) bps   40   bps Net (loss) income attributable to common stockh

      7/31/24 4:15:00 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary

    $CCRN
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by Cross Country Healthcare Inc.

      SCHEDULE 13G - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)

      5/9/25 12:24:57 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • SEC Form 10-Q filed by Cross Country Healthcare Inc.

      10-Q - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)

      5/7/25 4:45:32 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Cross Country Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)

      5/7/25 4:28:50 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary

    $CCRN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cash W Larry bought $61,320 worth of shares (6,000 units at $10.22), increasing direct ownership by 3% to 199,632 units (SEC Form 4)

      4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)

      12/31/24 5:15:10 PM ET
      $CCRN
      Professional Services
      Consumer Discretionary

    $CCRN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cross Country downgraded by Barrington Research

      Barrington Research downgraded Cross Country from Outperform to Mkt Perform

      12/10/24 9:21:19 AM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • JMP Securities initiated coverage on Cross Country

      JMP Securities initiated coverage of Cross Country with a rating of Mkt Perform

      12/6/23 7:33:30 AM ET
      $CCRN
      Professional Services
      Consumer Discretionary
    • Cross Country downgraded by Jefferies with a new price target

      Jefferies downgraded Cross Country from Buy to Hold and set a new price target of $21.00 from $32.00 previously

      11/3/23 7:41:51 AM ET
      $CCRN
      Professional Services
      Consumer Discretionary